NCT07512505 Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor
| NCT ID | NCT07512505 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Our Lady's Hospice and Care Services |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-11-06 |
| Primary Completion | 2026-11-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-11-06 with a primary completion date of 2026-11-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is the assess the use of remote monitoring of vital signs using commercially available medical devices in patients with advanced cancer admitted to a hospice inpatient unit for end-of-life care. The objectives of the study are: 1. could remote monitoring of vital signs improve patient care through the earlier identification of infections and other (potentially reversible) problems; 2. could remote monitoring of vital signs improve the accuracy of our estimates about how long a person has to live; and c) determine the relationship between complaints of pain / other symptoms and vital signs.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years old * Primary diagnosis of malignant disease * Admitted for end-of-life care (or focus of care changed to end-of-life care) * Estimated prognosis \< 14 days Exclusion Criteria: * Primary diagnosis of non-malignant disease * Inability to provide informed consent * Contraindications to use of biosensor adhesive patch (e.g. chest wall skin problem, allergy to adhesive)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07512505 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07512505 currently recruiting?
Yes, NCT07512505 is actively recruiting participants. Contact the research team at hgoffinet@olh.ie for enrollment information.
Where is the NCT07512505 trial being conducted?
This trial is being conducted at Dublin, Ireland.
Who is sponsoring the NCT07512505 clinical trial?
NCT07512505 is sponsored by Our Lady's Hospice and Care Services. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.